Postmenopausal osteoporosis with vertebral fracture: teriparatide vs romosozumab

IF 0.8 Q4 ENDOCRINOLOGY & METABOLISM

Revista de Osteoporosis y Metabolismo Mineral Pub Date : 2023-01-01 DOI:10.20960/revosteoporosmetabminer.00022

M. Muñoz Torres

引用次数: 0

查看原文本刊更多论文

绝经后骨质疏松伴椎体骨折:特立帕肽vs罗莫索单抗

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista de Osteoporosis y Metabolismo Mineral ENDOCRINOLOGY & METABOLISM-

CiteScore

0.80

自引率

16.70%

发文量

审稿时长

8 weeks

期刊介绍： The Journal of Osteoporosis and Mineral Metabolism (Rev Osteoporos Metab Miner; www.revistadeosteoporosisymetabolismomineral.es) is the official organ of scientific expression of the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM), who owns all rights over it. Its periodicity is quarterly (4 numbers a year, spring, summer, autumn and winter), with a variable number of extraordinary monographs. The third issue of the year, autumn, is intended for the publication of the communications of the annual Congress of the SEIOMM. The Journal of Osteoporosis and Mineral Metabolism (hereinafter ROMM) publishes works in Spanish, which will be translated into English, and is offered free of charge through its website.